FDA Import Refusal AEK-5756849-2/11/1 — ABBVIE
The FDA refused shipment AEK-5756849-2/11/1 from ABBVIE (France) on Apr 3, 2019. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 3, 2019
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 61YCY02 ADALIMUMAB
- Charges
- 75